Koers Repros Therapeutics Inc

Aandelen

26-01-18	Repros Announces Negative Opinion From the EMA for Enclomiphene
15-12-17	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency
12-12-17	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout
12-12-17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders
12-12-17	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc

Toevoegen aan een lijst 0 geselecteerde Om deze functie te gebruiken moet u een klant of lid zijn. Inloggen Registreren	Verschil (%)	Varia. 5d.	Varia. 1j.	Varia. 3j.	Kap.($)
REPROS THERAPEUTICS INC	-.--%	+0,74%	-	-	0
LONZA GROUP AG	+1,05%	+2,79%	+3,65%	+11,65%	50,44 mld.
REVOLUTION MEDICINES, INC.	+0,72%	+1,00%	+396,18%	+624,25%	40,63 mld.
IQVIA HOLDINGS INC.	+2,54%	+0,93%	+28,98%	-3,62%	34,88 mld.
BEONE MEDICINES AG	+0,31%	+1,74%	+18,44%	+59,76%	33,67 mld.
CELLTRION, INC.	-2,09%	-1,98%	+3,21%	+33,56%	26,29 mld.
ASCENDIS PHARMA A/S	-0,63%	+0,34%	-	-	17,11 mld.
MEDPACE HOLDINGS, INC.	+0,66%	-3,96%	+66,85%	+127,36%	15,29 mld.
IONIS PHARMACEUTICALS, INC.	-23,90%	-21,43%	+50,06%	+53,83%	10,62 mld.
EUROFINS SCIENTIFIC SE	+1,28%	+0,46%	+14,95%	+22,37%	13,74 mld.
Gemiddelde	-2,00%	-2,71%	+72,79%	+116,15%	26,96 mld.
Gewogen gemiddelde per kap.	-0,45%	-0,61%	+87,59%	+139,86%

Werknemers

Sector